Drugs / Potassium-sodium citrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01329042 | May 2005 → Oct 2007 | nephrolithiasis, calcium oxalate | Ouiheng International Healthcare Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Potassium-sodium citrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01329042 ↗ |
| Route | Oral | “given oral potassium-sodium citrate” NCT01329042 ↗ |